Skip to main content
PepGen Inc. logo

PepGen Inc. — Investor Relations & Filings

Ticker · PEPG ISIN · US7133171055 US Professional, scientific and technical activities
Filings indexed 272 across all filing types
Latest filing 2025-11-14 Major Shareholding Noti…
Country US United States of America
Listing US PEPG

About PepGen Inc.

https://pepgen.com

PepGen Inc. is a clinical-stage biotechnology company focused on developing the next generation of oligonucleotide therapeutics. The company's proprietary Enhanced Delivery Oligonucleotide (EDO) technology is designed to safely and effectively deliver drug candidates to target the root cause of severe neuromuscular and neurological diseases. PepGen is advancing a pipeline of disease-modifying therapies with the goal of transforming treatment for patients with debilitating genetic disorders.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2025
Major Shareholding Notification
2025-11-14 English
8-K
Regulatory Filings
2025-11-12 English
10-Q
Interim / Quarterly Report Q3 2025
2025-11-12 English
8-K
Regulatory Filings
2025-11-07 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-03 English
8-K
Regulatory Filings
2025-10-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.